Hospital-Acquired Infection Control Market 2024 - Trend Analysis, Industry Growth, Key Players, Growth Opportunities And Outlook By 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Hospital-Acquired Infection Control Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $41.37 billion In 2028 At A CAGR Of 4.8% :

The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $33.01 billion in 2023 to $34.35 billion in 2024 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing antibiotic resistance, growing awareness, stringent regulations, globalization of infectious diseases, patient safety initiatives.

The hospital-acquired infection control market size is expected to see steady growth in the next few years. It will grow to $41.37 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, international collaboration. Major trends in the forecast period include adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, shift towards single-use and disposable devices, emphasis on staff training and education, increased utilization of disinfection technologies.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp

Hospital-Acquired Infection Control Market Major Segments
The hospital-acquired infection control market covered in this report is segmented -

1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users

Key Driver - Hospital-Acquired Infection Control In The Covid-19 Era

The surge in COVID-19 cases is expected to propel the growth of the hospital-acquired infection control market going forward. COVID-19 refers to a viral infection that is caused by the SARS-CoV-2 virus. Due to the COVID-19 pandemic, there is an increase in demand for hospital-acquired infection control products and services to focus on personal hygiene and the production of infection control medical supplies. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, as of 8th August 2022, the global COVID-19 cases reached 581.6 million. Therefore, the surge in COVID-19 cases is driving the growth of the hospital-acquired infection control market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=7694&type=smp

Prominent Trend - Technology'S Pivotal Role In The Hospital-Acquired Infection Control Market

Technological advancements are a key trend gaining popularity in the hospital-acquired infection control market. Major companies operating in the hospital-acquired infection control market are focused on developing new technological solutions to lead the market. For instance, in November 2021, the scientists of University of Pittsburgh School of Medicine and Carnegie Mellon University, used machine learning technology with whole genome sequencing to rapidly detect infectious disease outbreaks in a hospital. Significant outbreaks that might otherwise escape routine infection prevention monitoring are discovered by this method.

Hospital-Acquired Infection Control Market Players
Major companies operating in the hospital-acquired infection control market report are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Sterigenics International LLC, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the hospital-acquired infection control market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Hospital-Acquired Infection Control Market Report Structure
3. Hospital-Acquired Infection Control Market Trends And Strategies
4. Hospital-Acquired Infection Control Market - Macro Economic Scenario
5. Hospital-Acquired Infection Control Market Size And Growth
…..
27. Hospital-Acquired Infection Control Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.